SCHEMBL7985608

SCHEMBL7985608

O=c1[nH]c(-c2ccc(F)cc2)nc2ncn(CCCc3ccccc3)c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
MAPK1 P28482 2/20 0.53
KDM4E B2RXH2 1/20 0.53
POLB P06746 1/20 0.53
CNOT7 Q9UIV1 3/20 0.47
TNKS O95271 1/20 0.44
TNKS2 Q9H2K2 1/20 0.44
PARP2 Q9UGN5 1/20 0.44
TSHR P16473 2/20 0.44
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KMT2A Q03164 2/20 0.41
HPGD P15428 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RECQL P46063 1/20 0.39
MDM2 Q00987 1/20 0.39
HTT P42858 1/20 0.39
BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7973869 0.94 TNKS (0.46) LMNAMAPK1KDM4EPOLBCNOT7
SCHEMBL7984240 0.92 LMNA (0.58) LMNAMAPK1KDM4EPOLBCNOT7
SCHEMBL7984488 0.89 LMNA (0.53) LMNAMAPK1KDM4EPOLBCNOT7
SCHEMBL7974290 0.89 KDM4E (0.50) LMNAMAPK1KDM4EPOLBCNOT7
SCHEMBL7991648 0.88 KDM4E (0.54) LMNAMAPK1KDM4EPOLBCNOT7
SCHEMBL7974505 0.87 SMN1; SMN2 (0.55) LMNACNOT7TNKSTNKS2PARP2
SCHEMBL7974613 0.85 CNOT7 (0.49) LMNAMAPK1KDM4EPOLBCNOT7
SCHEMBL7984463 0.85 KDM4E (0.53) LMNAMAPK1KDM4EPOLBCNOT7
SCHEMBL7974041 0.83 KDM4E (0.51) LMNAMAPK1KDM4EPOLBCNOT7
SCHEMBL7985605 0.83 CNOT7 (0.54) LMNAMAPK1KDM4EPOLBCNOT7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed